Human Vaccines & Immunotherapeutics (Apr 2020)
CIMT 2019: report on the 17th Annual Meeting of the Association for Cancer Immunotherapy
- Jan David Beck,
- Matthias Birtel,
- Erik Haefner,
- Isabell Sofia Keil,
- Daniel Reidenbach,
- Nadja Salomon,
- Ikra Gizem Yildiz,
- Mustafa Diken
Affiliations
- Jan David Beck
- TRON-Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH
- Matthias Birtel
- TRON-Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH
- Erik Haefner
- TRON-Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH
- Isabell Sofia Keil
- TRON-Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH
- Daniel Reidenbach
- TRON-Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH
- Nadja Salomon
- TRON-Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH
- Ikra Gizem Yildiz
- TRON-Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH
- Mustafa Diken
- TRON-Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH
- DOI
- https://doi.org/10.1080/21645515.2019.1675459
- Journal volume & issue
-
Vol. 16,
no. 4
pp. 808 – 815
Abstract
No abstracts available.Keywords
- cimt
- cancer immunotherapy
- tumor vaccination
- cellular therapy
- combination therapy
- tumor microenvironment
- checkpoint blockade
- personalized therapy
